White Papers

Peptide mapping is a critical workflow in biotherapeutic protein characterization and is essential for elucidating the primary amino acid structure of proteins.

Developing a combination product, there are many things to consider. With early design involvement, there is a greater opportunity for success.

Bayer Pharma AG uses thermal and chemical unfolding experiments with nanoDSF to find optimal buffer conditions for IgG antibodies.

In a collaborative study with Novartis Institutes for Biomedical Research, a thermal unfolding assay using nanoDSF is applied to understanding the stabilizing effects of ligands on G protein-coupled receptors. See how nanoDSF provides an easy solution for this difficult target.

nanoDSF is a new and powerful tool for rapid screening approaches in biosimilar development. It enables narrowing down the number of promising candidates in hours instead of days or weeks. Download the full application note to learn more.

Fully automated analysis of antibody formulations using chemical and thermal denaturation

Comparison of nanoDSF and µDSC for thermal stability assessment during biopharmaceutical formulation development

Nemera’s has developped a new generation of 2-steps autoinjector for fluid and viscous injections.

The only user-independent multi-dose nasal spray system on the market

Nemera’s Device Equivalence Program has been established to respond to market enquiries in terms of nasal spray equivalence and second-sourcing needs